NextCure, Inc. (NXTC)
Pharmaceutical Preparations
Latest Price
$6.37
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.30
P/B Ratio
2.77
Institutional Ownership
41.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 288.3K | -- | 7.09% | +50.0K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 277.2K | -- | 6.81% | -- | 2026-06-30 |
| Sofinnova Investments, Inc. | 222.7K | -- | 5.47% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 171.2K | -- | 4.21% | +110.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 156.8K | -- | 3.85% | -- | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 88.1K | -- | 2.17% | +75.1K | 2026-06-30 |
| BOOTHBAY FUND MANAGEMENT, LLC | 84.7K | -- | 2.08% | +15.1K | 2026-06-30 |
| Squadron Capital Management LLC | 64.5K | -- | 1.58% | -200.5K | 2026-06-30 |
| Verdad Advisers, LP | 60.5K | -- | 1.49% | +17.5K | 2026-06-30 |
| Pfizer Inc | 44.3K | -- | 1.09% | -109.0K | 2026-06-30 |